Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Myelin Imaging in Concussed High School Football Players

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03698747
Recruitment Status : Terminated (PI left organization)
First Posted : October 9, 2018
Last Update Posted : September 25, 2020
Sponsor:
Information provided by (Responsible Party):
Memorial Healthcare System

Brief Summary:
Investigate myelin alterations in high school football players with mTBI

Condition or disease Intervention/treatment
Traumatic Brain Injury Device: McDESPOT

Detailed Description:

The lack of highly sensitive clinical neuroimaging and neuropsychiatric markers of subtle changes due to mTBI makes it difficult to characterize injury severity and to predict outcomes. White matter tracts in the brain, both myelinated and non-myelinated, are susceptible to damage from impact-acceleration forces experienced during a TBI,5-7 and there is evidence that significant white matter injury and myelin loss occurs in mTBI. In addition, this damage may be chronic and can negatively affect neural processing speed and cognitive function. Traditional anatomical and function MRI imaging sequences include clinical sequences such as traditional T1 and T2 sequences, fluid-attenuated inversion recovery (FLAIR), three-dimensional (3D) magnetization-prepared rapid gradient echo (MP-RAGE), diffusion-weighted imaging (DWI) and gradient MRI. While a number of advanced imaging techniques, notably magnetization transfer, diffusion tensor and quantitative T1 and T2 imaging (MTI, DTI, qT1 and qT2, respectively), have been used previously to study white matter in neurosurgical diseases, these methods provide only indirect, non-specific information related to myelin content. For example, these modalities can tell when there is swelling that is affecting the movement of water, which may be indicative of a process that would affect myelin, but they cannot give specific information about the amount of myelin surrounding a nerve. An emerging multicomponent relaxometry technique, termed multicomponent driven equilibrium single pulse observation of T1 and T2 (mcDESPOT), provides a voxel-wise estimation ranging from 0 to 1 for myelin content, with higher values providing an indirect marker of greater myelin integrity. Two studies have shown increased myelin after injury in football and ice hockey players.8 DTI, which primarily gives information about the myelin-axon bundle interactions, has shown decreased fractional anisotropy after mTBI,myelin-axon bundle interactions, has shown decreased fractional anisotropy after mTBI, indicating that the myelin that is present is less organized.8 Combining mcDESPOT and DTI findings, it is possible to see a more nuanced picture of the remyelination process after mTBI. In the present program, the investigators propose adding the mcDESPOT sequence to the MRI scanner in accordance with the MRI manufacturer's technical requirements. Although the sequences obtained for mcDESPOT are nearly identical sequences used in clinical practice, the flip-angles are changed so that they cannot be read like a traditional image.

Rather, the data have to be post-processed by a computer in order to be able to derive myelin information. The mcDESPOT sequences are FDA approved, and present no additional risk over traditional clinical MRI sequences. Apolipoprotein E (ApoE) is a class of proteins involved in the metabolism of fats in the body, and is important in Alzheimer's disease and cardiovascular disease. How the body makes this protein is genetically coded in the APoE gene. One form of this gene, APoE allele 4 (APoE4) is found in about 25% of the population, but in 60% of patients with Alzheimer's dementia. Infants with this allele also show decreased myelination at a young age. It is postulated that this defect affects the brain's ability to myelinate and remyelinate, leading to decreased or disorganized myelination, which then leads to an increased risk for development of dementia. This study aims to build upon preliminary data collected by the principal investigator (PI) showing increased but disorganized myelin in collegiate football players, by confirming and reproducing these results in a larger population. This study will also add the component of genetic testing for the APoE4 allele to see if there is a sub-segment of the study population that may be at increased risk for brain injury after mTBI and subsequent findings in the research scans. The mcDESPOT and genetic testing findings will also be correlated with routine neuropsychology concussion assessment results.

Layout table for study information
Study Type : Observational
Actual Enrollment : 13 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: A Prospective Study of Myelin Imaging Changes in Concussed High School Football Players
Actual Study Start Date : September 4, 2018
Actual Primary Completion Date : August 12, 2020
Actual Study Completion Date : August 12, 2020

Group/Cohort Intervention/treatment
mTBI Study Group with McDESPOT sequence
Study group (30 subjects) of football players diagnosed with mTBI (scan at diagnosis, 3-month follow-up scan, genetic screening, concussion assessment at both interaction)
Device: McDESPOT
myelin specific MRI sequence (mcDESPOT) added to standard MRI sequence

Control Group
Control group (30 subjects) of age match non-contact sport players (scan, genetic testing, concussion assessment)



Primary Outcome Measures :
  1. Myelin Disruption on MRI brain scan [ Time Frame: 3 months ]
    Determine whether mTBI in football players leads to increased, but disorganized, myelin compared to non-contact sports players.


Secondary Outcome Measures :
  1. APoE4 allele genetic mutation on blood test [ Time Frame: 3 months ]
    Explore whether a genetic mutation in the APoE4 allele predisposes football players to decreased or disorganized myelination after mTBI.

  2. Neuropsychiatric concussion correlation [ Time Frame: 3 months ]
    Correlate any changes in myelination or of genetics with neuropsychiatric concussion assessment.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   13 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   Male
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Male high school football players
Sampling Method:   Non-Probability Sample
Study Population
High school age (9th-12th grade), male, right-handed Diagnosed with concussion or mild traumatic brain injury
Criteria

Inclusion Criteria:

  • Experimental Group

    • Patient age range: 9th through 12th grade (high school)
    • Male
    • Right-handed
    • Diagnosis of mTBI or concussion during a football game or training
    • No significant co-morbidities
    • Able to get an MRI
    • Potential subject must be capable of giving informed consent or assent when applicable

      • Control Group

    • Patient age range: 9th through 12th grade (high school)
    • Male Right-handed
    • Does not play contact sports (football, soccer, lacrosse)
    • No significant co-morbidities
    • Able to get an MRI
    • Potential subject must be capable of giving informed consent or assent when applicable

Exclusion Criteria:

  • Unable to tolerate MRI scan

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03698747


Locations
Layout table for location information
United States, Florida
Memorial Healthcare System
Hollywood, Florida, United States, 33021
Sponsors and Collaborators
Memorial Healthcare System
Investigators
Layout table for investigator information
Principal Investigator: Heather Spader, MD Memorial Healthcare System
Layout table for additonal information
Responsible Party: Memorial Healthcare System
ClinicalTrials.gov Identifier: NCT03698747    
Other Study ID Numbers: MTBI
First Posted: October 9, 2018    Key Record Dates
Last Update Posted: September 25, 2020
Last Verified: September 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Product Manufactured in and Exported from the U.S.: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Brain Injuries
Brain Injuries, Traumatic
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Craniocerebral Trauma
Trauma, Nervous System
Wounds and Injuries